The relationship between CD4+CD25+CD127LowTregs and TGF-β1 and IL-10 levels, and the analysis of the differences in immune status of patients with liver cancer are expected to provide valuable and diagnostic reference data for clinical treatment, the disease course, and prognosis of liver cancer. This evidence concerns the gene TGFB1 and liver cancer.